LPRC - CrimeScience – The Weekly Review: Episode 23 – Dr. Read Hayes, Tony D’Onofrio, and Tom Meehan

Episode Date: September 3, 2020

COVID-19 accounts for most 2020 cyberattacks. Amazon Fresh, Amazon’s grocery delivery service, opens in California. Apparel sees an increase in sales. This, & more, including information on positive COVID-19 test rates, therapies & vaccine trials, new data from Retail Dive, brand intimacy, school shopping, curbside retail, online forums & violence, and cyber-security advice in this LPRC Crimescience: The Weekly Review episode co-hosted by Dr. Read Hayes, Tom Meehan, and Tony D’Onofrio. The post CrimeScience – The Weekly Review: Episode 23 – Dr. Read Hayes, Tony D’Onofrio, and Tom Meehan appeared first on Loss Prevention Research Council.

Hi everyone, welcome to Crime Science. In this podcast, we aim to explore the science of crime and the practical application of the science for loss prevention and asset protection practitioners, as well as other professionals. We would like to thank Bosch for making this episode possible. Take advantage of the advanced video capabilities offered by Bosch to help reduce your shrink risk. Integrate video recordings with point-of-sale data for visual verification of transactions and exception reporting. data for visual verification of transactions and exception reporting. Use video analytics for immediate notification of important AP-related events and leverage analytics metadata for fast forensic searches for evidence and to improve merchandising and operations. Learn more about extending your video system beyond simple surveillance in zones one through four of LPRC's zones of influence by visiting Bosch online at boschsecurity.com.

All right, welcome everybody to another episode of Crime Science, the podcast. Today is another in our series of weekly updates from our panel, going through what's going on in everything that we need to know in asset protection and loss prevention. We're going to touch on some of the points there in that rich data set of need. And as always, I'm joined by our esteemed colleagues. We've got Kevin Tran, our producer, Tony D'Onofrio, and Tom Meehan. Today, I'll kind of start off and talk a little bit about, of course, COVID, what we're dealing with. But most importantly, we've been trying to maintain some contact and highlight a little bit around what the incredible science, technology, medicine community around the entire globe working 24-7 on the issue. on the issue. And so when it comes down to, we're looking at, first of all, in the United States, the positivity test rates, right? Just the percentage of tests that are administered daily, what percent of those are indicating positive for the coronavirus? They're seeing the COVID-19

show up in some form, the RNA strands and so on. We see that that's continuing to decrease over the last 30, almost 40 days now. Nationwide, it's getting down to 6% and continues to decline. In some of the high infectivity rate states, we're seeing the same, Arizona, Florida, California, and others. There's continued to, I would not say plunge, but continue to decrease. There seems to be a lot of continued physical distancing and mask wearing that is most likely playing a large role in the reduction in positive testing. Now with schools and colleges, universities going back in session, many of them, whether they're physical or not, I know here at the University of Florida,

we can tell when anywhere you move around the city of Gainesville, students are back in waves and masses. But most of the students have either all or the vast majority of their courses are online now. So, it'll be interesting to see what happens. I know here they took a gator pledge, if you will, that they would mask up and just the eyeball test of moving around as I drive around or walk around, whether on campus or even nearby, which is more significant, I'm impressed at how many students are walking around with their sporting their new Gator orange and blue mask. But they all sign these pledges.

So it's very, very interesting. And let's see if we can maintain the compliance. And particularly because the students you were humans were very, very social peoples and students more than most. So we'll see how that goes. But again, testing right now is indicating nationwide a continued decrease. I understand now the CDC has come out with data on sort of assessing and looking at death certificates that have been issued. And I think looking at randomized samples of those death certificates nationwide, trying to determine or discern an individual who died of COVID-19 and those that died with COVID-19,

looking at underlying other comorbidities, if you will, underlying conditions and so on, and just getting a better idea about what that might look like, what's a better understanding of the infection rate, and of course, the all too scary fatality rate to assess the virus in a much quicker fashion than we normally do, it sounds like in the medical field, that can take years or decades to really understand. the medical field that can take years or decades to really understand. And that's going to be the case here. But so far, I guess the indications are that it can be a serious disease, of course. It can be a fatal disease, but may not be as fatal as other viruses that we've been confronted with. We certainly know it's not like on Ebola scale or even close or even some of the other

epidemics or even like the 1918 pandemic as far as lethality but let's stay tuned and see where that comes out as just another data point in understanding the disease and its spread last week talked about what the united states was up against. The administration froze China travel in late January, and that seemed to start to freeze. But, you know, it's obviously evidence is that there was a lot of infiltration of the virus and the disease on both east and west coast, almost simultaneously, which seemed to preclude the idea that the disease could be started, the spread of the virus could be stopped as rapidly, particularly amongst 330 million people. And in great particularity in New York, Seattle, other places where you're going to see hundreds

of thousands or even millions of humans clustered very, very tightly. Even as the virus is diagnosed, there were still big gatherings in San Francisco and other places, just going out on the streets, partying, going to restaurants and so on. So that seemed to be part. We also talked about that in normal situations for decades, a century, that in normal situations for decades, a century, the county health department is the on-the-ground units or institutions that deal with any type of infectious diseases normally at a great scale, including developing their own testing, handling their own testing, their outreach, their infection testing, or I'm sorry, tracking and so

on. They became overwhelmed at a rate because of the infectivity rate of the COVID-19 that, or this SARS virus that they just couldn't handle it. It took a little while for the larger testing labs to be approved. It was sped up dramatically, but those regulations were in place. So we're looking at some of that. And then again, now we're still seeing that 40% to 60% of those of us that have been infected with COVID-19 are just asymptomatic or almost subclinically symptomatic. asymptomatic or almost subclinically symptomatic. But yet many of us at some percentage are super spreaders. And so again, it's this asymptomatic and pre-symptomatic, low symptomatic, high, high percentage of infection that in addition to the bi-coastal introduction, and then the overwhelming burden on local county health

departments that created what we're talking about. And that's a nationwide pandemic. And it still looks like out of 330 plus million of us here, that there's a relatively small percent that have been infected. But is it 8% or is it 15% or 16% is what, again, the scientists are trying to understand. We talk a lot about testing. Again, now, last week, we talked about 30, 36-minute tests that are very, very accurate,

very reliable and valid. And so now new ones have been introduced to my understanding that are now 15-minute tests. There's probably a little more, possibly a little more false positivity or false negative type 1 or type 2 errors there. But the idea of having a $1 to $5 15-minute feedback test that people can self-administer is a pretty powerful one. And it looks like that is now here. I understand the manufacturers are ramping up and that they'll be able to provide 10, 20 million pretty soon at a monthly rate, starting out with several million per month. So look forward to that. I think a lot of that kind of testing is going to help play a huge role in getting some

kind of handle on the disease, on the virus itself. Another interesting thing out there is the idea, if you look at the breakdown between tests, of course, on the front end, therapies for those of us that are now infected and are displaying some type of clinical, you know, we're presenting with some kind of clinical symptoms. But particularly those of us that get a more serious version of the disease, where are we with that? We know they're now closing in on 200 antivirals and testing. 61% of those antivirals are new, designed for COVID-19,

for the SARS-CoV-2 virus. So, 27% are redirected. There was a therapy that was used for another virus, maybe even another coronavirus in development that's been focused sharply on this particular novel coronavirus. 12% were repurposed. It's just an existing antiviral for some reason, or it may have been for cancer treatment and other therapies. But when you look at the treatments that are available now and coming out, the therapies themselves, in addition to the antiviral therapy, we've got about 330, 340 treatments out, therapies out now that are not antiviral. They're different mode or method of action type antiviral or non-antiviral,

excuse me. But in this case, 61% of those are redirected non-antiviral therapies, 31% repurposed, and only 8% are actually new for this particular virus. Vaccines, we know that there are now 23 phase one vaccines where it's the early safety and dose ranging or trying to understand how much and how often or how many times should we be dosed. 14 are in phase two. These are expanded safety and efficacy and dose ranging trials. 14 different vaccines are in phase two now. Phase three, just since we last talked,

we've gone from seven to nine vaccines in large-scale efficacy tests or phase three trialing. Again, we've still got three vaccines approved for early or limited use now in China and so on. So you can start to see some real good movement. some real good movement. I know that there are concerns out there by people across the board around any vaccine that seems to be somewhat limited, but particularly a vaccine that didn't take years of testing, but rather months of testing. So again, it looks like in this case, particularly the United States, the UK, and others. And even in China, there are continued 30,000 to 50,000 person phase threes. Many of these vaccines are going through multiple phase

three trials instead of just one trial. They've expanded. It looks like in most cases, those that are reviewing in the United States, of course, is going to go to the NIH, National Institutes of Health, and then to FDA and other testing for approval or review for approval. But expanding the boards, the review boards, having external review boards, so that more and more physicians and scientists are able to evaluate all the data that are out there, rerun numbers and so on. but do these things in parallel instead of, again, waiting for years for everybody to review. So by having larger scale trials, having multiple phase three large-scale trials, and then by having multiple reviewers evaluating and re-establishing and looking at the data, that's going to be, that's sort of what's going on right now to increase that.

The next point, of course, is manufacturing. We know with Operation Warp Speed, the administration and Congress came up with funds for moving vaccines through the approval process with a little more haste, but no less rigor, but then starting to build or repurposing viral producing factories or other factories that were more readily repurposed for the manufacturing process instead of waiting. So many of the nine vaccines that are currently

in large-scale efficacy tests in phase three, they're manufacturing those vaccines. In some cases, several million have already been produced. So if and when they're approved through rigorous phase three trialing and through multiple reviews, then there'll be millions available. There are teams in different universities, in the National Institutes of Health, private organizations, and so on, too, that have been running models and developing the distribution protocol, particularly the vaccines that might require refrigeration or at least cooler temperatures in countries or areas, even the United States, that have very few or no distribution resources. So every country in the world has rural areas, or most countries, or low-resourced areas, if you will. They don't have much of a medical infrastructure, if any at all. So those logistics and that planning is underway

and has been actually for the last two or three months. So that's good news. Who's going to be prioritized to receive vaccines? That also has been in a lot of planning and modeling. Frontline healthcare workers, those that are most exposed, those are the most vulnerable because of comorbidities, age, and so on. And so working through models to understand. But again, because of multiple factories, multiple vaccines, and much more efficient distribution models and actual rehearsals and things going on, the idea is that if a person may not need to wait for too long, if it requires two injections, like the anti-shingles that were all pretty much recommended to get over age 50. In this case,

Shingrix version that I got, it was two injections that were X amount of months apart. So that may be the case with one or more of the vaccines to really make sure that there's a robust immune response that's good enough to combat and sustain. We talked also last week about systemic versus localized, that the large muscles evidently are the best place in a lot of cases for a viral vaccine onboarding site. Our shoulders, the deltoid muscle is the most common evidently. shoulders, the deltoid muscle is the most common, evidently. But some are also developing nasal delivery models like we see with children and so on for the influenza vaccines, because that might provide an almost sterilization of the all

important nasal passages so that not only is the individual now got systemic protection from the injected vaccine, but maybe a nasal version or some complementary vaccine, particularly for super spreaders and so on, might protect other people from them until the full effect of the systemic or in addition to, because that may protect the individual that's been vaccinated through injection, but they still are carrying the virus in their nasal passages and so on. So that's just a little more than we maybe all wanted to know. But I think the good news, again, is that there is massive, very rigorous scientific

evaluation. And now we're talking about hundreds of therapies and dozens and dozens of vaccines that are under production and rigorous review through three different phases and multiple boards. So I think the next thing is looking over at LPRC very quickly. I always want to encourage everybody to go to the lpresearch.org website, the Knowledge Center. There contains all kind of working group notes. Again, we've got seven working groups working on a variety of issues

from supply chain protection, in-store merchandise protection, violent crime reduction in all forms, including now looking at anti-maskers and how do we safely address the issue so that others are not infected or even intimidated, since there seems to be avoidance behavior continuing where good customers who are either vulnerable themselves are fearful or live with vulnerable people are still not going into stores, or are going into stores and only buying limited amounts, or selecting items, but somebody in line is not protecting them and

others, much less themselves by not wearing a mask or not wearing it properly. Their nose is hanging out and so on. So that's kind of going on right now in these working groups, those sorts of discussions and pulling together research that's being done. We saw the CDC guidance come out about suggested or possible ways to handle people that are refusing to wear masks in these public places and most importantly in those spaces

and what the fallout could be. In the LPRC Knowledge Center, we also have, of course, a lot of webinars. We continue to upload our webinars in there. Offender interviews, we've done literally hundreds of offenders of interviews and we continue to do offender interviews. Most of those, if not many,

are uploaded into the LPRC Knowledge Center. And then there's much, much more up in there that we'd recommend. Also, bear in mind that LPRC does have a YouTube channel that's available to anyone where you'll see all kind of fantastic content that's put out by LPRC. We also encourage everybody to go ahead and subscribe. It's free. It's short. It's punchy. It looks really good. The LPRC Connect e-newsletter. Again, there's a landing page on lpresearch.org.

Just like we've talked about before, there's a landing page for COVID-19, a landing page for looting and other physical protection methods and research that's going on. Impact, LPRC Impact 2020, the virtual version. We will be going live as well as having a lot of pre-recorded content, 12 highly impactful, we believe, sessions on October 6th and 7th. You can go again to lpresearch.org

for free registration. Pass it on. Get yourself, your colleagues involved, whether they're APLP or non-APLP, in these discussions understanding science-based or evidence-based practice, but looking at real-world research in action that's going on where retailers are describing alongside the researcher colleagues what they're doing, what they're finding, what that means. The AI, the AR, the VR, the IoT development and testing and repurposing that's going on here at LPRC continues. Developing data sets, cleaning them, annotating them so that we've got higher quality data sets to use to train artificial intelligence models.

Right now, computer vision is our focus. And working with many of our sponsor members, Malang, for example, NVIDIA, EverSeen, Bosch, Axis, Sensormatic AI, and others working on training and then developing models for inferencing, developing either analytical or real-time decision support engines and so on. And then looking at the response protocols, what's it look like if we picked up a potential threat. So a lot of exciting things

going on at LPRC, LPRC Innovate, curbside pickup development, mobile and other self-checkout development, and so on. So I'm going to go ahead here and summarize that there's a lot happening in the world and there's a lot happening hopefully here at the LPRC to support you and your teams and your success for everybody's guardianship and protection. With no further ado, Tony D'Onofrio, if I might head over to you, Tony, and let's, what's going on around the U S and the world. Thank you very much, Reed.

So I'm going to start actually with Amazon this morning. So Amazon just opened their first full line grocery store outside of Whole Foods in California. It's called Amazon Fresh. It's 35,000 square feet, so much larger than the Amazon Go that we used to from Amazon in the past. It offers free same day delivery and pickup. If you have an Amazon Prime account, shoppers can order ahead for deli, meat, seafood, and even pizzas using the Amazon app. It marks the launch of their smart shopping cart, which they're calling the Amazon Dash Cart,

where you basically are scanning everything inside your cart, and then you're walking right out the door using the smart cart as your checkout devices. Throughout the store is Alexa so you can stand in an aisle and say, Alexa where can I find this spaghetti? And Alexa will respond and tell you where to go find the spaghetti. It also has an interface so you can create an Alexa shopping list and then you'll be guided to Alexa into the store and really this store reinforces what's happening to the online world which is companies like Amazon that figured out that they do

need physical stores they are an important element of the mix you need a balance between online and physical so they acquired Whole Foods and now they're opening their own grocery stores, full-line grocery stores, because if you look at Walmart, that is a lot of their success, and even Target is coming from buy online, pick up in stores, especially in grocery. So you're going to see a lot more physical stores coming from Amazon into the future.

So that's a little bit about Amazon. I'm going to switch to apparel. New data from Retail Dive this week that there are some glimmers of hope after most of us have not been buying clothes, but we started to go back. About 29% to 30% of us have started buying clothes again. The variables, the chains that are winning, the ones that are getting the business are the following. They're an offline retailer.

They're operating away from a mall. They're selling more than apparel. They're selling casual clothing. They have a strong e-commerce and or services model like buy online, pick up in stores. They have good inventory management so they know what they have, where they have it. And they're not a department store because department stores are expected to be the worst performing segment this year with a 691% decline. So department store is where it's really struggling, especially in the apparel space.

So department stores is where it's really struggling, especially in the apparel space. Also, a new study this week from NBLM in terms of brand intimacy. So this is a larger study on how consumers are emotionally attached to brands. And retail is actually the fourth industry in line out of 15 industries that they analyze in terms of brand attachment, emotional brand attachment. The top five most intimate retail brands in 2020 are number one, we just talked about it, Amazon, number two, Walmart, number three, Costco, number four, Target, and number five, Whole Foods. That was a surprise. And of course, they're owned by Amazon. Let me now switch a little bit to back to school shopping and what's happening there since that's in full gear right now. A new compared card survey, 67% of our

parents are stressed about paying for back to school-school supplies versus 43% last year. Three in 10 parents expect to go into debt up from 26% last year. Most expect to spend 12% more to an average of about $500. One in five expect shopping-related fights with their children in terms of what they're going to buy. So that should be fun to watch. 44% plan to shop mostly online versus 13% last year. So it gives you an idea how much of the online world really is impacting this year during the pandemic. Talking to the pandemic, let me give you a quick update in terms of what's going on with curbside retail. So curbside retail was extremely popular for Dick's

Sporting Goods and helped drive a record Q2. 75% of Dick's Sporting Goods orders in Q2 were fulfilled by stores, which again reinforces the importance of store and then these adjacent services at the curbside. Best Buy moved to only curbside in March and its online sales serves 242% in the quarter. And Best Buy is actually now working on adding a lot more services at the curb, including notifying you via the app when is the best time where you're not going to run into a collision in terms of too many people trying to pick up goods at the same time. And similar to what I reported last week, Walmart, so their online sales go up 97%, and a lot of it, again, was to pick up in store or at the curbside so

these services are becoming a lot more important to retail and i'm going to end with a new rsr research on retail business continuity so one of the questions they ask is how long and then these are questions that they ask to retailers how long long will COVID-19 be an issue, do you believe? So 11% said less than six months, 28% six to 12 months, 38% 12 to 18 months, and 12% 18 to 24 months. Another question that they ask is the percent rating is very important given the outbreak of COVID-19. And one of the things that RSR does really well, they segment the winners versus the others. And the winners are the ones that really have their act together. And these are the responses for the winners in terms of what they're focused on.

So 89% assess and stabilize remote operations at a hyper local level. 79% assess the health and wellness of their teams. 79% determine changes in consumer buying behavior. 71% understand where our teams are working from so they know exactly where their employees are located. 68% have the ability to adjust business plans based on local conditions. And then a couple other questions. Rate your company's capability to monitor compliance to community laws associated with the pandemic. And this has shocked me, but I guess it makes sense. The winners rated this capability to actually understand what's happening at the local level as excellent at 65%, very good at 29%, inadequate at 5%. So they really understand how to adjust to the local

laws. And I'll close with what this report reported and is critical to do for retailers right now. These are the critical things that they need to do as retailers right now. So number one, enable enterprise-wise accurate and near-time visibility to inventory, integrate order management with all the other selling channels, optimize fulfillment processes to cross-channel orders, and these will be to things like buy online to pick up in stores, replace legacy forecasting system with next generation solutions that can utilize new data to model demand at hyperlocal. So notice this theme of understanding what's happening at the enterprise level,

but actually managing to what's happening actually at the local level. So getting a lot more data from local stores to actually make those decisions. Identify critical operational processes, breakpoints, and automate exception alerts to enable a quick response. and automate exception alerts to enable a quick response, take a hard look at locations, determine which ones are most likely to survive, and consider new operational models. The winners have a handle on these two things,

the ability to report operational issues in real time, the ability to perform fast analysis using local data. So I thought that was interesting as we deal with these issues in terms of what some of the winners or the more exceptional retailers are doing to stay ahead of the crisis and actually manage to through the crisis to a new normal. And with that I'm going to turn it over to Tom. Thank you, Reed. Thank you, Tony. I'm going to go through a couple of things here. And I try not to be repetitive weekly, but I think some of the news is repetitive by nature. So I'm just going to touch on a couple of things. One just came out this last week, a report showing that the majority of cyber attacks are directly related to COVID-19 in 2020.

That's a pretty alarming kind of number if you think about what's going on in the globe, that the more organized hackers or criminals on the web are actually targeting COVID-19 related scams. I know we've covered that since the beginning prior to this being the weekly review when it was specific to COVID-19, but I thought it was very interesting that it went through. And when you look at that, it is a global number. And when we talked a little about this as well as last week, number. And when we talk a little bit, this is as well as last week when you're seeing increases of more than 90% in attack vectors specific to cyber security. Interpol also reported last week another assessment on the impact of COVID-19 and cyber crime. They did one in early August.

They did one in early August. They put another one and the significant shift from individuals and small businesses to institutions and larger infrastructure, critical infrastructure, major corporations. This is very, very concerning and should be for the listeners here that early on, this was a small business and medium size, small business, medium size, maybe potential. But kind of the typical targeted attacks, soft targets, if you will, now you're seeing a pretty significant shift to larger financial institutions, retailers, utility companies, and a huge, huge attack on the healthcare and schooling system. And that's mainly because there's changes in that system. Top cybersecurity experts report 4,000 cyber attacks a day on average since COVID-19 started. So just really, really telling numbers. And again, I think at the risk of being too repetitive, we know that this is

going to continue to happen. If you go to a U.S. report, I think I mentioned this last week, the FBI has seen four to five hundred percent increases in reported attacks. On last week's show, I also talked about digital risk protection. And I just think it's a great reminder that digital risk protection is not all about cybersecurity. It's about your digital footprint, and your digital footprint can be consumption of data. It could be your exception report data coming in, your marketing data, any data points, any digital points in your organization. any digital points in your organization. And I think it serves as a reminder as stores are now really open to just take a double look at some of those physical security measures to protect your digital infrastructure.

I think with all the things going on today, it's easy to get distracted. Switching gears a little bit to some of the chatter we're seeing on social media and open source from our open source intelligence gathering effort, we're continuing to look at a SOC lab concept here at the LPRC and really looking at a way that we can help support our members with a more robust offering for intelligence gathering. And it's just way more than intelligence gathering. It's response, what vectors we're looking at, how to really define and respond, what's going on. And I think you'll see a lot more coming out of that. We're really starting to nail down a phased approach

of how we'll consume that data and really get it out to the masses. And that leads me to the importance of not limiting your gathering platforms to a specific social media channel or channels and really to look at the total landscape of the Internet. And the example I'll give is Reddit, 4chan, some of these niche networks that are social and nefarious in nature, but not mainstream like your Facebooks and Twitters

of the world have a lot of great information, a lot of really, really substantial information related specifically to threat. Just this past week, I had gathered quite a bit of information specific to actors on both Reddit, 4chan, and Twitter, making statements about where police were going to be present, where people should meet to rally. And there was a stark difference in some of the communication from what I've

seen in the past around self-disturbance where there was very specific instruction to be violent and destructive. If you're going to meet here, actually one post wrote, if you're going to come meet here we're not taking the stance of laying quietly and peacefully protesting we're going to burn this city down and there were several posts that follow that around where to meet actually where to meet to pick up it didn't have specifics but to pick things up to

help with setting fires. So accelerants that actually said, come meet here. We have things to help get you into the town with fuel for fire. So I'm looking at some notes here. So some really crazy posts that we haven't seen that level of direct threat. posts that we haven't seen that level of direct threat um very open uh on twitter um on reddit unfortunately not hidden in private groups so very concerning data as well as out of chicago uh detroit and some chatter uh throughout california uh where gangs were speaking on social media and yes um there's a a lot of gang chatter about the importance of shooting police on sight.

That was actually one of the statements that was made in Chicago, is that the direction is how important it is for gangs to show the police that there is a target on their head if you will and one of the things that was interesting is that through these gangs that are considered rivals they were spreading the same messaging so we talk often about some of the challenges that law enforcement is facing again some of those of those overt conversations that are occurring is definitely concerning. And I'll round it out with just a reminder, and I know that we did this last week, but as school is starting to be in session for the Northeast,

and I know in some states it's already been in session, just a reminder to talk to your children about good cybersecurity habits, password safety, communication, and just another firm reminder to please, please, please keep your work computer separate than the computer that your children are using for school. I can't stress enough how important that will be in the next probably three to six months based on some of the activity that we're seeing as far as threat vectors. Well, thank you. And over to you, Reid.

And so I think what we'll do is a little bit about Crime Science the podcast. We've now put out dozens of episodes. We've got more that have just been released, those that have been recorded not released yet, and we're continuing to set up more with really interesting APLP practitioners, law enforcement practitioners, but obviously criminologists that are working in different areas, social network analysis, crime mapping, understanding risk terrain modeling,

but trying to talk to the people that are doing the research that are practicing and walking the walk as far as better understanding and focusing and trialing and testing and implementing and carrying out crime and loss control in the real world, in the real world with real humans that we all know that we are very unpredictable and are capable of all kind of not so great things when it comes to theft, fraud, and violence. In other words, victimizing other people and their places. So what we'll do, Kevin, are you able to give us some idea of some of the recently released Crime Science Podcast episodes and what's in the pipeline to come our way?

For sure. So recently we just released an episode with Dr. Laura Hewey, and she was from the Canadian Society of Evidence-Based Policing. That was just released last week. Check it out. We also have one upcoming with Dr. Ryland Simpson that should be released next week, and he is from SFU. And then in the future, we are recording a few episodes with Dr. Ali Mom from the California State University. And we're going to talk about policing and social policy with her. And then last but not least, we have longtime collaborator Nolan Scaife, who is now at the University of Colorado.

And we'll talk about cybersecurity with him on that episode coming up. And those should be the next few episodes. Stay tuned. Wow. Thanks so much, Kevin. All right. Well, everybody out there, please stay safe. So thanks so much, Kevin. Thank you, Tom. Thank you, Tony, for all your insights, your valuable time. And for you all out there listening to Crime Science, the podcast, signing off from Gainesville, this is Reed Hayes. Thank you very much. Thanks for listening to the Crime Science Podcast presented by the Loss Prevention Research Council and sponsored by Bosch Security. If you enjoyed today's episode,

you can find more Crime Science episodes and valuable information at lpresearch.org. The content provided in the Crime Science Podcast is for informational purposes only and is not a substitute for legal, financial, or other advice. Views expressed by guests of the Crime Science Podcast are those of the authors and do not reflect the opinions or positions of the Office of Prevention Research Council.